{"id":"W3156985612","doi":"10.1056/nejmoa2028485","title":"Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer","year":2021,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":1543,"is_retracted":false,"has_abstract":true,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Medicine; Internal medicine; Hazard ratio; Vinorelbine; Metastatic breast cancer; Oncology; Breast cancer; Chemotherapy; Eribulin; Gemcitabine; Cancer; Gastroenterology; Surgery; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05153200415118789,"score_gpt":0.3885479570907073,"score_spread":0.3370159529395194,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}